Loders Croklaan Group B.V. entered into an agreement to acquire Ioi Lipid Enzymtec Sdn Bhd from IOI Corporation Berhad (KLSE:IOICORP) for approximately MYR 330 million on January 19, 2018. Loders Croklaan Group B.V. will operate Ioi Lipid Enzymtec Sdn Bhd as wholly owned subsidiary. The transaction has no impact on IOI Corporation's consolidated financial.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.79 MYR | +2.43% |
|
+2.43% | -3.56% |
15/07 | IOI Corporation Berhad Reports Production Results for the Month of June 2024 | CI |
19/06 | IOI Elevates Oleochemical Industries Director to Deputy CEO | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.56% | 490.84Cr | |
+35.50% | 754.77Cr | |
-3.59% | 629.99Cr | |
+5.77% | 259.22Cr | |
+41.57% | 221.74Cr | |
+3.50% | 169.28Cr | |
+17.02% | 101.78Cr | |
+18.18% | 93Cr | |
+8.26% | 72Cr | |
-18.15% | 69Cr |
- Stock Market
- Equities
- IOICORP Stock
- News IOI Corporation
- Loders Croklaan Group B.V. entered into an agreement to acquire Ioi Lipid Enzymtec Sdn Bhd from IOI Corporation Berhad for approximately MYR 330 million.